Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 4
2004 1
2005 3
2006 6
2007 3
2008 2
2009 3
2010 8
2011 5
2012 5
2013 4
2014 7
2015 5
2016 5
2017 2
2018 5
2019 3
2020 5
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy.
Aizawa R, Takayama K, Nakamura K, Ogata T, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Tashiro Y, Ota H, Ogawa O, Mizowaki T. Aizawa R, et al. Among authors: takayama k. Int J Urol. 2021 Jul;28(7):749-755. doi: 10.1111/iju.14567. Epub 2021 Apr 2. Int J Urol. 2021. PMID: 33811409 Free article.
Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer.
Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T. Aizawa R, et al. Among authors: takayama k. Urol Oncol. 2021 Feb;39(2):131.e9-131.e15. doi: 10.1016/j.urolonc.2020.09.026. Epub 2020 Oct 27. Urol Oncol. 2021. PMID: 33127301
Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer.
Sato GE, Aizawa R, Nakamura K, Takayama K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T. Sato GE, et al. Among authors: takayama k. J Radiat Res. 2020 Jul 6;61(4):622-628. doi: 10.1093/jrr/rraa044. J Radiat Res. 2020. PMID: 32583860 Free PMC article.
[MRI Connecting Functions and Anatomy: A New Bridge for Radiotherapy].
Iima M, Iizuka Y, Matsuo Y, Takayama K, Nakamoto Y, Yamamoto A, Kataoka M, Ishimori T, Mizowaki T, Togashi K. Iima M, et al. Among authors: takayama k. Igaku Butsuri. 2020;40(1):3-7. doi: 10.11323/jjmp.40.1_3. Igaku Butsuri. 2020. PMID: 32238681 Free article. Japanese.
Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy.
Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T. Aizawa R, et al. Among authors: takayama k. Int J Clin Oncol. 2020 Apr;25(4):713-719. doi: 10.1007/s10147-019-01596-7. Epub 2019 Dec 9. Int J Clin Oncol. 2020. PMID: 31820209 Free article. Clinical Trial.
Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.
Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T. Aizawa R, et al. Among authors: takayama k. Int J Clin Oncol. 2019 Oct;24(10):1247-1255. doi: 10.1007/s10147-019-01478-y. Epub 2019 May 31. Int J Clin Oncol. 2019. PMID: 31152322 Free PMC article.
69 results